据《Lancet》1999年354卷第9181期报道 艾滋病的临床试验已经表明,在发达国家中,zidovudine预防性治疗HIV-1感染的孕妇及其孩子,与没有母乳喂养妇女的HIV-1垂直传播显著增加有关。美国约翰·霍普金斯大学医学院L.A.Guay医生等,对分娩时和出生后第一个14～16周nevirapine和zidovudine短程治疗的安全性和有效性进行了对比。于1997年12月～1999年4月,在乌干达的Mulago医院共 A clinical trial of AIDS reported in Lancet, Volume 354, September 1999, No. 9181, has shown that zidovudine prophylactic treatment of HIV-1-infected pregnant women and their children in developed countries is significantly more likely to spread HIV-1 than women who are not breast-fed Increase related. L.A.Guay, MD, of Johns Hopkins University School of Medicine in the United States compared the safety and efficacy of nevirapine and zidovudine for short-term treatment at the time of delivery and after the first 14 to 16 weeks of life. From December 1997 to April 1999, at Mulago Hospital in Uganda